Clinical resource
Anesthesia drug shortages
Drug shortages that affect anesthesia and perioperative care, drawn from the FDA and curated for South Carolina physician anesthesiologists. The Society tracks these so you can see at a glance what is in short supply.
Drawn from the FDA’s public Drug Shortages database; for awareness, not a basis for care decisions.
Latest changes
Recently updated
The most recent status changes the FDA posted for the drugs on this list.
- Nov 9, 2026Atropine Sulfate InjectionIn shortage
- Nov 9, 2026Bupivacaine Hydrochloride, Epinephrine Bitartrate InjectionIn shortage
- Nov 9, 2026Bupivacaine Hydrochloride InjectionIn shortage
- Nov 9, 2026Fentanyl Citrate InjectionIn shortage
- Nov 9, 2026Hydromorphone Hydrochloride InjectionIn shortage
- Nov 9, 2026Ketorolac Tromethamine InjectionIn shortage
- Nov 9, 2026Lidocaine Hydrochloride InjectionIn shortage
- Nov 9, 2026Meperidine Hydrochloride InjectionIn shortage
- Nov 9, 2026Midazolam Hydrochloride InjectionIn shortage
- Nov 9, 2026Morphine Sulfate InjectionIn shortage
The list
Shortages by drug
31 drugs tracked, 18 currently in shortage. As of November 10, 2026. Search for a drug, narrow the list by status, and open any drug to see its affected presentations.
31 drugs listed.
Atropine Sulfate Injection
In shortageInjection · 8 companies
Reasons: Discontinuation of the manufacture of the drug; Other; Requirements related to complying with good manufacturing practices
Updated Nov 9, 2026
17 presentationsHide detailsPresentation Company Status Updated FDA note Atropine Sulfate, Injection, 0.25 mg/5 mL (0.05 mg/mL) Syringes (NDC 0409-9630-05)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Atropine Sulfate, Injection, .1 mg/1 mL (NDC 76329-3340-1)Available Amphastar Pharmaceuticals, Inc. In shortage Nov 6, 2026 None Atropine Sulfate, Injection, .4 mg/1 mL (NDC 0517-1004-25)Available American Regent, Inc. In shortage Nov 3, 2026 On allocation Atropine Sulfate, Injection, .4 mg/1 mL (NDC 63323-580-20)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Next release November 2026. Check wholesalers for inventory. Atropine Sulfate, Injection, 1 mg/1 mL (NDC 0517-1001-25)Available American Regent, Inc. In shortage Nov 3, 2026 None Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-525-08)Unavailable Accord Healthcare Inc. In shortage Nov 2, 2026 Estimated availability: December 2026 Atropine Sulfate, Injection, 1 mg/1 mL (NDC 16729-526-08)Unavailable Accord Healthcare Inc. In shortage Nov 2, 2026 Estimated availability: December 2026 Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 64253-400-91)Available Medefil, Inc. In shortage Nov 2, 2026 None Atropine Sulfate, Injection, 0.1 mg/1 mL (NDC 16729-484-45)Available Accord Healthcare Inc. In shortage Nov 2, 2026 None Atropine Sulfate, Injection, .4 mg/1 mL (NDC 70069-631-25)Available Somerset Therapeutics, LLC In shortage Oct 27, 2026 None Atropine Sulfate, Injection, 1 mg/1 mL (NDC 70069-641-25)Available Somerset Therapeutics, LLC In shortage Oct 27, 2026 None Atropine Sulfate, Injection, .4 mg/1 mL (NDC 70069-481-10)Available Somerset Therapeutics, LLC In shortage Oct 27, 2026 None Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 0409-1630-10)Limited Availability Hospira, Inc., a Pfizer Company In shortage Oct 21, 2026 Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay Atropine Sulfate, Injection, .05 mg/1 mL (NDC 16729-483-03)Unavailable Accord Healthcare Inc. In shortage Oct 17, 2026 Discontinuation of the manufacture of the drug Atropine Sulfate, Injection, .1 mg/1 mL (NDC 16729-484-90)Unavailable Accord Healthcare Inc. In shortage Oct 17, 2026 Discontinuation of the manufacture of the drug Atropine Sulfate, Injection, 0.4 mg/1 mL (NDC 0641-6251-10)Available Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 None Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-512-43)Unavailable Accord Healthcare Inc. In shortage Oct 3, 2026 Estimated recovery: TBD Bupivacaine Hydrochloride Injection
In shortageInjection · 8 companies
Reasons: Delay in shipping of the drug; Demand increase for the drug; Discontinuation of the manufacture of the drug; Other
Updated Nov 9, 2026
60 presentationsHide detailsPresentation Company Status Updated FDA note Marcaine, Injection, 25 mg/10 mL (2.5 mg/mL) (NDC 0409-2510-01)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Bupivacaine Hydrochloride, Injection, 25 mg/10 mL (2.5 mg/mL) (NDC 0409-1159-01)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Marcaine, Injection, 250 mg/50 mL (NDC 0409-0525-25)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 Historical NDC: 0409-1610-50 Bupivacaine Hydrochloride, Injection, 75 mg/30 mL (2.5 mg/mL) (NDC 0409-1159-02)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Bupivacaine Hydrochloride, Injection, Bupivacaine Spinal 15 mg/2 mL (7.5 mg/mL in 8.25% dextrose) (NDC 0409-3613-01)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Marcaine, Injection, 225 mg/30 mL (NDC 0409-2253-25)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 Historical NDC: 0409-1582-29 Marcaine, Injection, Marcaine 225 mg/30 mL (7.5 mg/mL) (NDC 0409-2253-01)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 Historical NDC: 0409-1582-29 Marcaine, Injection, 150 mg/30 mL (5 mg/mL) (NDC 0409-1530-01)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Marcaine, Injection, 75 mg/30 mL (2.5 mg/mL) (NDC 0409-7535-01)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Bupivacaine Hydrochloride, Injection, 125 mg/50 mL (2.5 mg/mL) (NDC 0409-1160-01)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Bupivacaine Hydrochloride, Injection, 225 mg/30 mL (7.5 mg/mL) (NDC 0409-1165-02)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Bupivacaine Hydrochloride, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-1162-01)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Marcaine, Injection, 0.75% 15 mg/2 mL (NDC 0409-1761-62)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Bupivacaine Hydrochloride, Injection, 150 mg/30 mL (5 mg/mL) (NDC 0409-1162-02)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Bupivacaine Hydrochloride, Injection, 250 mg/50 mL (5 mg/mL) (NDC 0409-1163-01)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Marcaine, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-5010-01)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-37)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Sensorcaine, Injection, 7.5 mg/1 mL (NDC 63323-472-17)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-31)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Estimated recovery: TBD Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-467-57)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-37)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-17)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-31)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Estimated recovery: TBD Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-17)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-465-57)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Sensorcaine, Injection, 7.5 mg/1 mL (NDC 63323-472-37)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 73293-0002-2)Unavailable Huons Co., Ltd In shortage Nov 2, 2026 Estimated recovery: TBD Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 70069-752-01)Unavailable Somerset Therapeutics, LLC In shortage Oct 27, 2026 Estimated recovery: June 2027 Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 70069-752-10)Unavailable Somerset Therapeutics, LLC In shortage Oct 27, 2026 Estimated recovery: June 2027 Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 70069-752-25)Available Somerset Therapeutics, LLC In shortage Oct 27, 2026 None Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-753-25)Unavailable Somerset Therapeutics, LLC In shortage Oct 27, 2026 Estimated recovery: June 2027 Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-753-10)Unavailable Somerset Therapeutics, LLC In shortage Oct 27, 2026 Estimated recovery: June 2027 Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-753-01)Unavailable Somerset Therapeutics, LLC In shortage Oct 27, 2026 Estimated recovery: June 2027 Marcaine, Injection, 0.75% 15 mg/2 mL (7.5 mg/mL) in Dextrose 8.25% (NDC 0409-1761-10)Unavailable Hospira, Inc., a Pfizer Company In shortage Oct 21, 2026 Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay Marcaine, Injection, Marcaine 75 mg/10 mL (7.5 mg/mL) (NDC 0409-1165-01)Available Hospira, Inc., a Pfizer Company In shortage Oct 21, 2026 None Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 55150-171-10)Available Eugia US LLC In shortage Oct 19, 2026 Check wholesalers for inventory Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-168-30)Available Eugia US LLC In shortage Oct 19, 2026 Check wholesalers for inventory Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-250-50)Available Eugia US LLC In shortage Oct 19, 2026 Check wholesalers for inventory Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 55150-172-30)Available Eugia US LLC In shortage Oct 19, 2026 Check wholesalers for inventory Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-169-10)Available Eugia US LLC In shortage Oct 19, 2026 Check wholesalers for inventory Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-249-50)Available Eugia US LLC In shortage Oct 19, 2026 Check wholesalers for inventory Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-167-10)Available Eugia US LLC In shortage Oct 19, 2026 Check wholesalers for inventory Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-170-30)Available Eugia US LLC In shortage Oct 19, 2026 Check wholesalers for inventory Bupivacaine Hydrochloride PRESERVATIVE FREE, Injection, 2.5 mg/1 mL 5mg / 1mL (NDC 72266-263-10)Available ONESOURCE SPECIALTY PTE LTD In shortage Sep 18, 2026 Distributed by Fosun Pharma USA Inc. Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 31722-276-34)Available Aspiro Pharma Limited In shortage Jul 17, 2026 None Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 31722-277-34)Available Aspiro Pharma Limited In shortage Jul 17, 2026 None Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 31722-276-32)Available Aspiro Pharma Limited In shortage Jul 17, 2026 None Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 31722-277-32)Available Aspiro Pharma Limited In shortage Jul 17, 2026 None Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 31722-275-34)Available Aspiro Pharma Limited In shortage Jul 17, 2026 None Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 31722-275-32)Available Aspiro Pharma Limited In shortage Jul 17, 2026 None Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-726-52) Kindos Pharmaceuticals Co. Ltd. To be discontinued May 5, 2026 Discontinuation of the manufacture of the drug Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-725-32)Limited Availability Kindos Pharmaceuticals Co. Ltd. In shortage May 5, 2026 Meitheal Pharmaceuticals is distributor/labelerMore from the FDA Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 71288-728-32)Limited Availability Kindos Pharmaceuticals Co. Ltd. In shortage May 5, 2026 Meitheal Pharmaceuticals is distributor/labelerMore from the FDA Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-725-32) Kindos Pharmaceuticals Co. Ltd. To be discontinued May 5, 2026 Discontinuation of the manufacture of the drug Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-722-32)Limited Availability Kindos Pharmaceuticals Co. Ltd. In shortage May 5, 2026 Meitheal Pharmaceuticals is distributor/labelerMore from the FDA Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-722-32) Kindos Pharmaceuticals Co. Ltd. To be discontinued May 5, 2026 Discontinuation of the manufacture of the drug Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-723-52) Kindos Pharmaceuticals Co. Ltd. To be discontinued May 5, 2026 Discontinuation of the manufacture of the drug Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-723-52)Limited Availability Kindos Pharmaceuticals Co. Ltd. In shortage May 5, 2026 Meitheal Pharmaceuticals is distributor/labelerMore from the FDA Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 71288-728-32) Kindos Pharmaceuticals Co. Ltd. To be discontinued May 5, 2026 Discontinuation of the manufacture of the drug Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-726-52)Limited Availability Kindos Pharmaceuticals Co. Ltd. In shortage May 5, 2026 Meitheal Pharmaceuticals is distributor/labelerMore from the FDA Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection
In shortageInjection · 2 companies
Reasons: Delay in shipping of the drug; Demand increase for the drug; Other
Updated Nov 9, 2026
26 presentationsHide detailsPresentation Company Status Updated FDA note Marcaine with Epinephrine, Injection, Marcaine™ 0.5% 150 mg/30 mL (5 mg/mL) with Epinephrine 1:200,000 (as bitartrate) Single Dose Vial Novaplus (NDC 0409-4208-10)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Marcaine with Epinephrine, Injection, Marcaine™ 0.5% 50 mg/10 mL (5 mg/mL) with Epinephrine 1:200,000 (as bitartrate) Single Dose Vial Novaplus (NDC 0409-8126-10)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Marcaine with Epinephrine, Injection, Marcaine™ 0.5% 250 mg/50 mL (5 mg/mL) with Epinephrine 1:200,000 (as bitartrate) Multiple Dose Vial Novaplus (NDC 0409-6581-01)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Marcaine with Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 50 mg/10 mL (5 mg/mL 1:200,000) (NDC 0409-1749-10)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Marcaine with Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 250 mg/50 mL (5 mg/mL 1:200,000) (NDC 0409-1755-50)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Marcaine with Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 150 mg/30 mL (5 mg/mL 1:200,000) (NDC 0409-1749-29)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Marcaine with Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 25 mg/10 mL (2.5 mg/mL 1:200,000) (NDC 0409-1746-10)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Marcaine with Epinephrine, Injection, Marcaine™ 0.25% 75 mg/30 mL (2.5 mg/mL) with Epinephrine 1:200,000 (as bitartrate) Single Dose Vial Novaplus (NDC 0409-1541-10)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Marcaine with Epinephrine, Injection, Marcaine™ 0.25% 25 mg/10 mL (2.5 mg/mL) with Epinephrine 1:200,000 (as bitartrate) Single Dose Vial Novaplus (NDC 0409-5738-10)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Marcaine with Epinephrine, Injection, Marcaine™ 0.25% 125 mg/50 mL (2.5 mg/mL) with Epinephrine 1:200,000 (as bitartrate) Multiple Dose Vial Novaplus (NDC 0409-3812-01)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Marcaine with Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 75 mg/30 mL (2.5 mg/mL 1:200,000) (NDC 0409-1746-30)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Sensorcaine, Injection, 7.5 mg/1 mL; .005 mg/1 mL (NDC 63323-460-37)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesaler for inventory Sensorcaine, Injection, 2.5 mg/1 mL; .005 mg/1 mL (NDC 63323-461-57)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Next release November 2026. Check wholesalers for inventory. Sensorcaine, Injection, 2.5 mg/1 mL; .005 mg/1 mL (NDC 63323-468-17)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-17)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Sensorcaine, Injection, 2.5 mg/1 mL; .005 mg/1 mL (NDC 63323-468-37)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesaler for inventory Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-463-57)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-31)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Estimated recovery: TBD Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-37)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Next release November 2026. Check wholesalers for inventory. Marcaine with Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 125 mg/50 mL (2.5 mg/mL 1:200,000) (NDC 0409-1752-50)Limited Availability Hospira, Inc., a Pfizer Company In shortage Oct 29, 2026 Limited Supply Available. Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay Bupivacaine Hydrochloride with Epinephrine, Injection, 125 mg/50 mL (2.5 mg/mL) (NDC 0409-9043-01)Unavailable Hospira, Inc., a Pfizer Company In shortage Oct 29, 2026 Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay Bupivacaine Hydrochloride with Epinephrine, Injection, 75 mg/30 mL (2.5 mg/mL) (NDC 0409-9042-17)Unavailable Hospira, Inc., a Pfizer Company In shortage Oct 29, 2026 Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay Bupivacaine Hydrochloride with Epinephrine, Injection, 150 mg/30 mL (5 mg/mL) (NDC 0409-9045-17)Unavailable Hospira, Inc., a Pfizer Company In shortage Oct 29, 2026 Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay Bupivacaine Hydrochloride with Epinephrine, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-9045-01)Unavailable Hospira, Inc., a Pfizer Company In shortage Oct 29, 2026 Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay Bupivacaine Hydrochloride with Epinephrine, Injection, 25 mg/10 mL (2.5 mg/mL) (NDC 0409-9042-01)Unavailable Hospira, Inc., a Pfizer Company In shortage Oct 29, 2026 Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay Bupivacaine Hydrochloride with Epinephrine, Injection, 250 mg/50 mL (5 mg/mL) (NDC 0409-9046-01)Unavailable Hospira, Inc., a Pfizer Company In shortage Oct 29, 2026 Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay View Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection on FDA.gov
Dexmedetomidine Hydrochloride Injection
In shortageInjection · 17 companies
Reasons: Delay in shipping of the drug; Demand increase for the drug; Discontinuation of the manufacture of the drug; Other
Updated Nov 6, 2026
60 presentationsHide detailsPresentation Company Status Updated FDA note Precedex, Injection, 1000 mcg/250 mL Single Dose Glass Bottle (NDC 0409-1434-01)Available Pfizer Inc. In shortage Nov 6, 2026 None Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-1660-50)Available Pfizer Inc. In shortage Nov 6, 2026 None Precedex, Injection, 200 mcg/50 mL (NDC 0409-7838-24)Available Pfizer Inc. In shortage Nov 6, 2026 None Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-1454-20)Available Pfizer Inc. In shortage Nov 6, 2026 None Precedex, Injection, 1000 mcg/250 mL Glass Bottle NovaPlus (NDC 0409-2815-01)Available Pfizer Inc. In shortage Nov 6, 2026 None Precedex, Injection, 80 mcg/20 mL (4 mcg/mL) (NDC 0409-3301-10)Available Pfizer Inc. In shortage Nov 6, 2026 None Precedex, Injection, 80 mcg/20 mL (4 mcg/mL) (NDC 0409-1660-20)Available Pfizer Inc. In shortage Nov 6, 2026 None Precedex, Injection, 400 mcg/100 mL (NDC 0409-7853-24)Available Pfizer Inc. In shortage Nov 6, 2026 None Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-4596-20)Available Pfizer Inc. In shortage Nov 6, 2026 None Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-0155-02)Available Pfizer Inc. In shortage Nov 6, 2026 None Precedex, Injection, 1000 mcg/250 mL (NDC 0409-7875-12)Available Pfizer Inc. In shortage Nov 6, 2026 None Precedex, Injection, 200 mcg/2 mL (100 mcg/mL) (NDC 0409-1638-02)Available Pfizer Inc. In shortage Nov 6, 2026 None Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-1596-10)Available Pfizer Inc. In shortage Nov 6, 2026 None Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-1174-10)Available Pfizer Inc. In shortage Nov 6, 2026 None Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 63323-671-20)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Expected recovery: TBD Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 43066-555-24)Available Baxter Healthcare In shortage Nov 3, 2026 None Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 63323-671-00)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Expected recovery: TBD Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 0338-9557-12)Available Baxter Healthcare In shortage Nov 3, 2026 None Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 67457-924-50)Available Mylan Institutional, a Viatris Company In shortage Nov 3, 2026 None Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 43066-557-12)Available Baxter Healthcare In shortage Nov 3, 2026 None Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 0338-9555-24)Available Baxter Healthcare In shortage Nov 3, 2026 None Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 63323-671-50)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Estimated recovery: TBD Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 67457-925-10)Available Mylan Institutional, a Viatris Company In shortage Nov 3, 2026 None Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 63323-421-02)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Estimated recovery: TBD Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 67457-251-02)Available Mylan Institutional, a Viatris Company In shortage Nov 3, 2026 None Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 42023-187-10)Unavailable Par Health, USA LLC In shortage Nov 2, 2026 Estimated recovery: TBD; Please check wholesalers for inventory Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 44567-600-04)Available HQ Specialty Pharma In shortage Nov 2, 2026 Marketed by WG Critical Care Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 42023-186-20)Unavailable Par Health, USA LLC In shortage Nov 2, 2026 Estimated recovery: TBD; Please check wholesalers for inventory Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 42023-146-25)Unavailable Par Health, USA LLC In shortage Nov 2, 2026 Please check wholesalers for inventory Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 44567-603-24)Available HQ Specialty Pharma In shortage Nov 2, 2026 Marketed by WG Critical Care Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 44567-601-04)Available HQ Specialty Pharma In shortage Nov 2, 2026 Marketed by WG Critical Care Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 44567-602-24)Available HQ Specialty Pharma In shortage Nov 2, 2026 Marketed by WG Critical Care Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 70069-759-04)Available Somerset Therapeutics, LLC In shortage Oct 27, 2026 None Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 70069-758-04)Available Somerset Therapeutics, LLC In shortage Oct 27, 2026 None Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 43598-976-58)Available Gland Pharma Limited In shortage Oct 21, 2026 Distributed by DRL Dexmedetomidine Hydrochloride, Injection, 200 ug/2 mL (NDC 66794-230-42)Available Gland Pharma Limited In shortage Oct 21, 2026 Marketed by Piramal Critical Care Inc.: 800-414-1901 Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 43598-975-58)Available Gland Pharma Limited In shortage Oct 21, 2026 Distributed by DRL Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 55150-297-10)Available Eugia US LLC In shortage Oct 19, 2026 Check wholesalers for inventory Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 55150-209-02)Available Eugia US LLC In shortage Oct 19, 2026 Check wholesalers for inventory Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 55150-296-10)Available Eugia US LLC In shortage Oct 19, 2026 Check wholesalers for inventory Dexmedetomidine Hydrochloride, Injection, 400 mcg/100 mL (4 ug/1 mL) (NDC 52536-126-08)Available Azurity Pharmaceuticals, Inc In shortage Oct 15, 2026 Distributed by Wilshire Pharmaceuticals, Inc. Dexmedetomidine Hydrochloride, Injection, 200 mcg/50 mL (4 ug/1 mL) (NDC 52536-125-10)Available Azurity Pharmaceuticals, Inc In shortage Oct 15, 2026 Distributed by Wilshire Pharmaceuticals, Inc. Dexmedetomidine Hydrochloride, Injection, 400 mcg/100 mL (4 ug/1 mL) (NDC 72572-128-08)Available Azurity Pharmaceuticals, Inc In shortage Oct 15, 2026 Distributed by Civica Dexmedetomidine Hydrochloride, Injection, 200 mcg/50 mL (4 ug/1 mL) (NDC 72572-127-10)Available Azurity Pharmaceuticals, Inc In shortage Oct 15, 2026 Distributed by Civica Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 0143-9532-25)Available Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Additional product will be made available as it is released. Dexmedetomidine Hydrochloride, Injection, 200 mcg/2 mL (NDC 83634-600-02)Unavailable Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) In shortage Oct 14, 2026 Discontinuation of the manufacture of the drug; Distributed by Avenacy; Contact information: 877-283-6229More from the FDA Dexmedetomidine Hydrochloride, Injection, 200 mcg/2 mL (NDC 83634-600-02) Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) To be discontinued Oct 14, 2026 Discontinuation of the manufacture of the drug; Distributed by Avenacy; Contact information: 877-283-6229 Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 70121-1388-8)Available Amneal Pharmaceuticals In shortage Oct 6, 2026 None Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 70121-1389-7)Available Amneal Pharmaceuticals In shortage Oct 6, 2026 None Dexmedetomidine Hydrochloride, Injection, 200 mcg/50 mL (NDC 0781-3494-95)Available Jiangsu Hengrui Pharmaceuticals Co., Ltd. In shortage Oct 5, 2026 Marketed by Sandoz Inc.; Customer service: 800-525-8747 Dexmedetomidine Hydrochloride, Injection, 400 mcg/100 mL (NDC 0781-3495-95)Available Jiangsu Hengrui Pharmaceuticals Co., Ltd. In shortage Oct 5, 2026 Marketed by Sandoz Inc.; Customer service: 800-525-8747 Dexmedetomidine Hydrochloride, Injection, 4 mcg/mL, 50 mL (NDC 70121-1388-1)Available Amneal Pharmaceuticals In shortage Oct 5, 2026 None Dexmedetomidine Hydrochloride, Injection, 80 mcg/20 mL (NDC 0781-3493-95)Available Jiangsu Hengrui Pharmaceuticals Co., Ltd. In shortage Oct 5, 2026 Marketed by Sandoz Inc.; Customer service: 800-525-8747 Dexmedetomidine Hydrochloride, Injection, 4 mcg/mL, 100 mL (NDC 70121-1389-1)Available Amneal Pharmaceuticals In shortage Oct 5, 2026 None Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 16729-432-93)Unavailable Accord Healthcare Inc. In shortage Sep 15, 2026 Discontinuation of the manufacture of the drug Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 16729-239-93)Unavailable Accord Healthcare Inc. In shortage Sep 15, 2026 Discontinuation of the manufacture of the drugMore from the FDA Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 71288-505-03)Available Meitheal Pharmaceuticals, Inc. In shortage Aug 27, 2026 None Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 71225-126-05) Slayback Pharma To be discontinued Jun 5, 2026 Discontinuation of the manufacture of the drug Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 71225-126-06) Slayback Pharma To be discontinued Jun 5, 2026 Discontinuation of the manufacture of the drug Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 16729-239-93) Accord Healthcare Inc. To be discontinued Apr 21, 2026 Discontinuation of the manufacture of the drug Epinephrine Bitartrate, Lidocaine Hydrochloride Injection
In shortageInjection · 2 companies
Reasons: Demand increase for the drug; Other
Updated Nov 3, 2026
22 presentationsHide detailsPresentation Company Status Updated FDA note Xylocaine, Injection, .01 mg/1 mL; 20 mg/1 mL (NDC 63323-483-57)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-17)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Xylocaine, Injection, .01 mg/1 mL; 20 mg/1 mL (NDC 63323-483-27)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-37)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-17)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-27)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Next release November 2026. Check wholesalers for inventory. Xylocaine, Injection, .005 mg/1 mL; 15 mg/1 mL (NDC 63323-488-37)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-57)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Xylocaine, Injection, .005 mg/1 mL; 15 mg/1 mL (NDC 63323-488-17)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-17)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Next release November 2026. Check wholesalers for inventory. Xylocaine, Injection, .005 mg/1 mL; 5 mg/1 mL (NDC 63323-481-57)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Next release November 2026. Check wholesalers for inventory. Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-27)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Lidocaine Hydrochloride And Epinephrine, Injection, 300 mg/30 mL (1%; 1:100,000) (NDC 0409-3178-02)Unavailable Hospira, Inc., a Pfizer Company In shortage Oct 21, 2026 Next Delivery: January 2027; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay Lidocaine Hydrochloride And Epinephrine, Injection, 250 mg/50 mL (0.5%; 1:200,000) (NDC 0409-3177-01)Unavailable Hospira, Inc., a Pfizer Company In shortage Oct 21, 2026 Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay Lidocaine Hydrochloride and Epinephrine, Injection, 600 mg/30 mL (2%; 1:100,000) (NDC 0409-3182-02)Limited Availability Hospira, Inc., a Pfizer Company In shortage Oct 21, 2026 Limited Supply Available. Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay Lidocaine Hydrochloride And Epinephrine, Injection, 400 mg/20 mL (2%; 1:100,000) (NDC 0409-3182-01)Unavailable Hospira, Inc., a Pfizer Company In shortage Oct 21, 2026 Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay Lidocaine Hydrochloride And Epinephrine, Injection, 400 mg/20 mL (2%; 1:200,000) (NDC 0409-3183-01)Limited Availability Hospira, Inc., a Pfizer Company In shortage Oct 21, 2026 Limited Supply Available. Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay Lidocaine Hydrochloride And Epinephrine, Injection, 500 mg/50 mL (1%; 1:100,000) (NDC 0409-3178-03)Limited Availability Hospira, Inc., a Pfizer Company In shortage Oct 21, 2026 Limited Supply Available. Next Delivery: April 2027; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay Lidocaine Hydrochloride And Epinephrine, Injection, 200 mg/20 mL (1%; 1:100,000) (NDC 0409-3178-01)Limited Availability Hospira, Inc., a Pfizer Company In shortage Oct 21, 2026 Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay Lidocaine Hydrochloride And Epinephrine, Injection, 450 mg/30 mL (1.5%; 1:200,000) (NDC 0409-3181-01)Limited Availalbility Hospira, Inc., a Pfizer Company In shortage Oct 21, 2026 Limited Supply Available. Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay Lidocaine Hydrochloride And Epinephrine, Injection, 1 g/50 mL (2%; 1:100,000) (NDC 0409-3182-03)Limited Availability Hospira, Inc., a Pfizer Company In shortage Oct 21, 2026 Limited Supply Available. Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay Lidocaine Hydrochloride And Epinephrine, Injection, 75 mg/5 mL (1.5%; 1:200,000) (NDC 0409-1209-01)Unavailable Hospira, Inc., a Pfizer Company In shortage Oct 21, 2026 Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay View Epinephrine Bitartrate, Lidocaine Hydrochloride Injection on FDA.gov
Etomidate Injection
In shortageInjection · 6 companies
Reasons: Demand increase for the drug; Other
Updated Nov 3, 2026
18 presentationsHide detailsPresentation Company Status Updated FDA note Etomidate, Injection, 2 mg/1 mL (NDC 67457-902-10)Available Mylan Institutional, a Viatris Company In shortage Nov 3, 2026 None Etomidate, Injection, 2 mg/1 mL (NDC 67457-903-20)Available Mylan Institutional, a Viatris Company In shortage Nov 3, 2026 None Amidate, Injection, 2 mg/1 mL (NDC 0409-6695-01)Unavailable Hospira, Inc., a Pfizer Company In shortage Oct 21, 2026 Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay Etomidate, Injection, 2 mg/1 mL (NDC 72266-146-10)Available Gland Pharma Limited In shortage Oct 21, 2026 Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645. Etomidate, Injection, 2 mg/1 mL (NDC 72266-147-10)Available Gland Pharma Limited In shortage Oct 21, 2026 Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645. Amidate, Injection, 2 mg/mL (NDC 0409-6695-02)Unavailable Hospira, Inc., a Pfizer Company In shortage Oct 21, 2026 Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay Etomidate, Injection, 40 mg/20 mL (NDC 55150-222-20)Unavailable Eugia US LLC In shortage Oct 19, 2026 On backorder. Recovery: TBD. Check wholesalers for inventory Etomidate, Injection, 20 mg/10 mL (NDC 55150-221-10)Unavailable Eugia US LLC In shortage Oct 19, 2026 On backorder. Recovery: TBD. Check wholesalers for inventory Etomidate, Injection, 2 mg/1 mL (NDC 72572-161-10)Available Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Distributed by Civica Etomidate, Injection, 2 mg/1 mL (NDC 0143-9310-10)Available Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Novaplus label Etomidate, Injection, 2 mg/1 mL (NDC 72572-160-10)Available Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Distributed by Civica Etomidate, Injection, 2 mg/1 mL (NDC 0143-9311-10)Available Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Novaplus label Etomidate, Injection, 2 mg/1 mL (NDC 0143-9506-10)Available Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Additional product will be made available as it is released. Etomidate, Injection, 2 mg/1 mL (NDC 0143-9507-10)Available Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Additional product will be made available as it is released. Etomidate, Injection, 2mg/1 mL (NDC 65219-445-10)Available Caplin Steriles, Ltd. In shortage Jun 16, 2026 Check wholesalers for inventory; Marketed by Fresenius Kabi Etomidate, Injection, 2 mg/mL (NDC 72485-509-10)Available Caplin Steriles, Ltd. In shortage Jun 16, 2026 Check wholesalers for inventory; Marketed by Armas Pharmaceuticals, Inc. 908-803-2586 Etomidate, Injection, 2mg/mL (NDC 65219-447-20)Available Caplin Steriles, Ltd. In shortage Jun 16, 2026 Check wholesalers for inventory; Marketed by Fresenius Kabi Etomidate, Injection, 2 mg/mL (NDC 72485-508-10)Available Caplin Steriles, Ltd. In shortage Jun 16, 2026 Check wholesalers for inventory; Marketed by Armas Pharmaceuticals, Inc. 908-803-2586 Fentanyl Citrate Injection
In shortageInjection · 3 companies
Reasons: Demand increase for the drug; Other
Updated Nov 9, 2026
20 presentationsHide detailsPresentation Company Status Updated FDA note Fentanyl Citrate, Injection, 2,500 mcg/50 mL (50 mcg/mL) Single Dose Glass Fliptop Vial (NDC 0409-9094-55)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Fentanyl Citrate, Injection, 100 mcg/2 mL (50 ug/1 mL) (NDC 0409-9094-22)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Fentanyl Citrate, Injection, 2500 mcg/50 mL (50 ug/1 mL) (NDC 0409-9094-61)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-01)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-05)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 63323-808-11)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-20)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Next release December 2026. Check wholesalers for inventory. Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-02)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-50)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Next release December 2026. Check wholesalers for inventory. Fentanyl Citrate, Injection, 500 mcg/10 mL (50 ug/1 mL) (NDC 0409-9094-28)Limited Availability Hospira, Inc., a Pfizer Company In shortage Oct 21, 2026 Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026 Fentanyl Citrate, Injection, 250 mcg/5 mL (50 ug/1 mL) (NDC 0409-9094-25)Limited Availability Hospira, Inc., a Pfizer Company In shortage Oct 21, 2026 Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026 Fentanyl Citrate, Injection, 1000 mcg/20 mL (50 ug/1 mL) (NDC 0409-9094-31)Limited Availability Hospira, Inc., a Pfizer Company In shortage Oct 21, 2026 Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026 Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6247-25)Available Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released. Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6025-10)Unavailable Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Inventory available in vial presentations. Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6030-01)Available Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released. Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6027-25)Available Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released. Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6026-05)Unavailable Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Inventory available in vial presentations. Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6028-25)Available Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released. Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6024-10)Unavailable Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Inventory available in vial presentations. Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6029-25)Available Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released. Hydromorphone Hydrochloride Injection
In shortageInjection · 4 companies
Reasons: Demand increase for the drug; Other
Updated Nov 9, 2026
26 presentationsHide detailsPresentation Company Status Updated FDA note Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0409-3365-10)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Hydromorphone Hydrochloride, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-2634-05)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0409-2634-01)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Hydromorphone Hydrochloride, Injection, 4 mg/1 mL Syringes (NDC 0409-1304-31)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Hydromorphone Hydrochloride, Injection, 500 mg/50 mL (10 mg/mL) (NDC 0409-2634-50)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Hydromorphone Hydrochloride, Injection, 2 mg/1 mL Syringes (NDC 0409-1312-30)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-11)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Next release November 2026. Check wholesalers for inventory. Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 63323-853-25)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-15)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesaler for inventory Dilaudid, Injection, .2 mg/1 mL (NDC 76045-121-11)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Next release November 2026. Check wholesalers for inventory. Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-852-25)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Next release November 2026. Check wholesalers for inventory. Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-10)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Hydromorphone Hydrochloride, Injection, 4 mg/1 mL (NDC 63323-854-10)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-50)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-06)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Next release November 2026. Check wholesalers for inventory. Dilaudid, Injection, 2 mg/1 mL (NDC 76045-010-11)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Next release not available at this time. Check wholesalers for inventory. Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0018-01)Available Teva Pharmaceuticals USA, Inc. In shortage Nov 2, 2026 None Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0110-03)Available Teva Pharmaceuticals USA, Inc. In shortage Nov 2, 2026 None Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0113-03)Limited Availability Teva Pharmaceuticals USA, Inc. In shortage Nov 2, 2026 Estimated recovery: November 2026 Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 0409-1283-37)Unavailable Hospira, Inc., a Pfizer Company In shortage Oct 21, 2026 Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0409-1312-36)Limited Availability Hospira, Inc., a Pfizer Company In shortage Oct 21, 2026 Limited Supply Available. Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay Hydromorphone Hydrochloride, Injection, 0.25 mg/ 0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC 0409-1805-01)Unavailable Hospira, Inc., a Pfizer Company In shortage Oct 21, 2026 Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay Hydromorphone Hydrochloride, Injection, 1 mg/1 mL Syringes (NDC 0409-1283-31)Available Hospira, Inc., a Pfizer Company In shortage Oct 21, 2026 None Hydromorphone Hydrochloride, Injection, 0.5 mg/0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC 0409-4264-01)Limited Availability Hospira, Inc., a Pfizer Company In shortage Oct 21, 2026 Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-6254-01)Unavailable Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Product temporarily on backorder. Additional lots will be available in the November 2026 timeframe. Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-0121-25)Available Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. Ketorolac Tromethamine Injection
In shortageInjection · 7 companies
Reasons: Delay in shipping of the drug; Demand increase for the drug; Other
Updated Nov 9, 2026
22 presentationsHide detailsPresentation Company Status Updated FDA note Ketorolac Tromethamine, Injection, 60 mg/2 mL (30 mg/mL) (NDC 0409-3796-01)Unavailable Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01)Available Sagent Pharmaceuticals In shortage Nov 6, 2026 None Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02)Unavailable Sagent Pharmaceuticals In shortage Nov 6, 2026 Product in transit with expected delivery in December 2026 Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0338-0072-25)Available Baxter Healthcare In shortage Nov 3, 2026 None Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0338-0069-10)Unavailable Baxter Healthcare In shortage Nov 3, 2026 Estimated recovery: December 2026 Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 76045-107-10)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Estimated recovery: TBD Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 76045-104-10)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Estimated recovery: TBD Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-01)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Next release not available at this time. Check wholesalers for inventory. Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-02)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Next release not available at this time. Check wholesalers for inventory. Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 63323-161-01)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 76045-105-20)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Estimated recovery: TBD Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0409-3795-01)Unavailable Hospira, Inc., a Pfizer Company In shortage Oct 21, 2026 Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-119-25)Available Gland Pharma Limited In shortage Oct 21, 2026 Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645. Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01)Available Gland Pharma Limited In shortage Oct 21, 2026 None Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0409-3793-01)Unavailable Hospira, Inc., a Pfizer Company In shortage Oct 21, 2026 Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-118-25)Available Gland Pharma Limited In shortage Oct 21, 2026 Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645. Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6043-25)Unavailable Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Estimated recovery: TBD Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0641-6041-25)Unavailable Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Estimated recovery: TBD Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6042-25)Unavailable Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Estimated recovery: TBD Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 62332-599-25)Available Alembic Pharmaceuticals In shortage May 15, 2026 None Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 62332-600-25)Available Alembic Pharmaceuticals In shortage May 15, 2026 None Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 62332-601-25)Available Alembic Pharmaceuticals In shortage May 15, 2026 None Lidocaine Hydrochloride Injection
In shortageInjection · 8 companies
Reasons: Demand increase for the drug; Other
Updated Nov 9, 2026
60 presentationsHide detailsPresentation Company Status Updated FDA note Lidocaine Hydrochloride, Injection, 100 mg/5 mL (2%; 20 mg/mL) (NDC 0409-2066-05)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Lidocaine Hydrochloride, Injection, 40 mg/2 mL (2%; 20 mg/mL) (NDC 0409-4282-01)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Lidocaine Hydrochloride Preservative Free, Injection, 50 mg/5 mL (1%; 10 mg/mL) (NDC 0409-4713-02)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Lidocaine Hydrochloride Preservative Free, Injection, 300 mg/20 mL (1.5%; 15 mg/mL) (NDC 0409-4776-01)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Lidocaine Hydrochloride, Injection, 200 mg/10 mL (2%; 20 mg/mL) (NDC 0409-4282-02)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Lidocaine Hydrochloride Preservative Free In Plastic Container, Injection, 50 mg/5mL (1%, 10 mg/1 mL) Syringes (NDC 0409-9137-05)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Lidocaine Hydrochloride In Plastic Container, Injection, 200 mg/20 mL (1%; 10 mg/mL) (NDC 0409-4276-01)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Lidocaine Hydrochloride Preservative Free, Injection, 200 mg/5 mL (4%; 40 mg/mL) (NDC 0409-4283-01)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Lidocaine Hydrochloride In Plastic Container, Injection, 400 mg/20 mL (2%; 20 mg/mL) (NDC 0409-4277-01)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Lidocaine Hydrochloride, Injection, 250 mg/50 mL (0.5%; 5 mg/mL) (NDC 0409-4278-01)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Lidocaine Hydrochloride, Injection, 300 mg/30 mL (1%; 10 mg/mL) (NDC 0409-4279-02)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Lidocaine Hydrochloride In Plastic Container, Injection, 1,000 mg/50 mL (2%; 20 mg/mL) (NDC 0409-4277-02)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Lidocaine Hydrochloride In Plastic Container, Injection, 500 mg/50 mL (1%; 10 mg/mL) (NDC 0409-4276-02)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 76329-3390-1)Available Amphastar Pharmaceuticals, Inc. In shortage Nov 6, 2026 None Xylocaine, Injection, 20 mg/1 mL (NDC 63323-495-07)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-17)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Next release not available at this time. Check wholesalers for inventory. Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-37)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Xylocaine, Injection, 15 mg/1 mL (NDC 63323-493-97)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Estimated recovery: TBD Xylocaine, Injection, 5 mg/1 mL (NDC 63323-484-57)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Estimated recovery: TBD Lidocaine Hydrochloride Preservative Free, Injection, 20 mg/1 mL (NDC 63323-208-05)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Next release December 2026. Check wholesalers for inventory. Xylocaine, Injection, 15 mg/1 mL (NDC 63323-493-91)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Estimated recovery: TBD Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-27)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Next release December 2026. Check wholesalers for inventory. Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 63323-202-02)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-57)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Next release December 2026. Check wholesalers for inventory. Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-201-10)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Next release November 2026. Check wholesalers for inventory. Xylocaine, Injection, 5 mg/1 mL (NDC 63323-491-57)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-31)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Estimated recovery: TBD Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-57)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Xylocaine, Injection, 20 mg/1 mL (NDC 63323-495-27)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Xylocaine, Injection, 10 mg/1 mL (NDC 63323-485-27)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Xylocaine, Injection, 10 mg/1 mL (NDC 63323-485-57)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Next release November 2026. Check wholesalers for inventory. Xylocaine, Injection, 20 mg/1 mL (NDC 63323-496-97)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Estimated recovery: TBD Lidocaine Hydrochloride In Plastic Container, Injection, 10 mg/1 mL (NDC 63323-201-02)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-27)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Lidocaine Hydochloride, Injection, 50 mg/5 mL (NDC 83634-653-05)Available Anthea Pharma In shortage Nov 2, 2026 Distributed by Avenacy, LLC Lidocaine Hydrochloride, Injection, 300 mg/30 mL (NDC 83634-653-30)Available Anthea Pharma In shortage Nov 2, 2026 Distributed by Avenacy, LLC Lidocaine Hydrochloride, Injection, 20 mg/2 mL (NDC 83634-653-02)Available Anthea Pharma In shortage Nov 2, 2026 Distributed by Avenacy, LLC Lidocaine Hydrochloride, Injection, 100 mg/10 mL (NDC 83634-651-10)Available Anthea Pharma In shortage Nov 2, 2026 Distributed by Avenacy, LLC Lidocaine Hydrochloride, Injection, 500 mg/50 mL (NDC 83634-651-50)Available Anthea Pharma In shortage Nov 2, 2026 Distributed by Avenacy, LLC Lidocaine Hydrochloride, Injection, 200 mg/20 mL (NDC 83634-651-20)Available Anthea Pharma In shortage Nov 2, 2026 Distributed by Avenacy, LLC Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 73293-0001-2)Unavailable Huons Co., Ltd. (South Korea) In shortage Nov 2, 2026 Estimated recovery: TBD Lidocaine Hydrochloride In Plastic Container, Injection, 250 mg/50 mL (0.5%; 5 mg/mL) (NDC 0409-4275-01)Unavailable Hospira, Inc., a Pfizer Company In shortage Oct 21, 2026 Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay Lidocaine Hydrochloride Preservative Free In Plastic Container, Injection, 100 mg/5mL (2%,20 mg/1 mL) Syringes (NDC 0409-1323-05)Limited Availability Hospira, Inc., a Pfizer Company In shortage Oct 21, 2026 Limited Supply Available. Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay Lidocaine Hydrochloride Preservative Free, Injection, 20 mg/2 mL (1%; 10 mg/mL) (NDC 0409-4713-32)Unavailable Hospira, Inc., a Pfizer Company In shortage Oct 21, 2026 Next Delivery and Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-162-05)Available Eugia US LLC In shortage Oct 19, 2026 Check wholesalers for inventory Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-159-74)Unavailable Eugia US LLC In shortage Oct 19, 2026 On backorder. Recovery: TBD. Check wholesalers for inventory Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 55150-165-05)Unavailable Eugia US LLC In shortage Oct 19, 2026 On backorder. Recovery: mid-November 2026; Check wholesalers for inventory Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-254-10)Unavailable Eugia US LLC In shortage Oct 19, 2026 On backorder. Recovery: late-November 2026; Check wholesalers for inventory Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-163-30)Available Eugia US LLC In shortage Oct 19, 2026 Check wholesalers for inventory Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-161-02)Available Eugia US LLC In shortage Oct 19, 2026 Check wholesalers for inventory Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-164-02)Available Eugia US LLC In shortage Oct 19, 2026 Check wholesalers for inventory Lidocaine Hydrochloride, Injection, 10 mg/mL (NDC 55150-251-10)Available Eugia US LLC In shortage Oct 19, 2026 Check wholesalers for inventory Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-256-50)Unavailable Eugia US LLC In shortage Oct 19, 2026 On backorder. Recovery: TBD. Check wholesalers for inventory Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-255-20)Available Eugia US LLC In shortage Oct 19, 2026 Check wholesalers for inventory Lidocaine Hydrochloride, Injection, 10 mg/mL (NDC 55150-252-20)Unavailable Eugia US LLC In shortage Oct 19, 2026 On backorder. Recovery: late October 2026; Check wholesalers for inventory Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 0143-9577-10)Available Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. Lidocaine Hydrochloride, Preservative Free, Injection, 20 mg/1 mL (NDC 0143-9594-25)Available Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Additional lots are scheduled to be manufactured. Product will be made available as it is released. Lidocaine Hydrochloride, Preservative Free, Injection, 10 mg/1 mL (NDC 0143-9595-25)Unavailable Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Product temporarily on backorder. Additional lots will be available in the November 2026 timeframe. Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 0143-9575-10)Available Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 65282-1605-1)Unavailable Spectra Medical Devices, LLC In shortage Oct 8, 2026 Estimated recovery: TBD Meperidine Hydrochloride Injection
In shortageInjection · 2 companies
Updated Nov 9, 2026
6 presentationsHide detailsPresentation Company Status Updated FDA note Demerol, Injection, 25 mg/1 mL (NDC 0409-1176-30)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Demerol, Injection, 50 mg/1 mL (NDC 0409-1181-30)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Demerol, Injection, 50 mg/1 mL (NDC 0409-1178-30)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Meperidine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-6052-25)Available Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Additional lots are scheduled to be manufactured. Product will be made available as it is released. Meperidine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-6053-25)Available Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Additional lots are scheduled to be manufactured. Product will be made available as it is released. Meperidine Hydrochloride, Injection, 100 mg/1 mL (NDC 0641-6054-25)Available Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Additional lots are scheduled to be manufactured. Product will be made available as it is released. Midazolam Hydrochloride Injection
In shortageInjection · 6 companies
Reasons: Delay in shipping of the drug; Demand increase for the drug; Other
Updated Nov 9, 2026
30 presentationsHide detailsPresentation Company Status Updated FDA note Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2mL (1 mg/mL) (NDC 0409-2305-17)Limited Availability Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 Next Estimated Delivery and Estimated Recovery: December 2026 Midazolam Hydrochloride, Injection, 25 mg/5 mL (5 mg/mL) (NDC 0409-2596-03)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Midazolam Hydrochloride, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-2596-05)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Midazolam Hydrochloride Preservative Free, Injection, 5 mg/mL Single Dose Glass Fliptop Vial Novaplus (NDC 0409-2308-49)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Midazolam Hydrochloride, Injection, 10 mg/2 mL (5 mg/mL) Single Dose Glass Fliptop Vial Novaplus (NDC 0409-2308-50)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-02)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2 mL (NDC 76045-211-20)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Next release December 2026. Check wholesalers for inventory. Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-12)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-10)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Estimated recovery: TBD Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-25)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-25)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Next release November 2026. Check wholesalers for inventory. Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-10)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Estimated recovery: TBD Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 23155-601-41)Available Avet Pharmaceuticals, Inc. In shortage Nov 2, 2026 None Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 23155-601-42)Available Avet Pharmaceuticals, Inc. In shortage Nov 2, 2026 None Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-611-10)Available WG Critical Care In shortage Nov 2, 2026 Please check wholesalers and distributors for inventory. Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-610-10)Available WG Critical Care In shortage Nov 2, 2026 Please check wholesalers and distributors for inventory. Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 23155-600-41)Available Avet Pharmaceuticals, Inc. In shortage Nov 2, 2026 None Midazolam Hydrochloride Preservative Free, Injection, 10 mg/2 mL (5 mg/mL) (NDC 0409-2308-02)Unavailable Hospira, Inc., a Pfizer Company In shortage Oct 29, 2026 Next Delivery: November 2026; Estimated Recovery: December 2026 Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2mL (1 mg/mL) (NDC 0409-0001-25)Limited Availability Hospira, Inc., a Pfizer Company In shortage Oct 29, 2026 Limited Supply Available. Next Delivery: December 2026; Estimated Recovery: March 2027 Midazolam Hydrochloride Preservative Free, Injection, 5 mg/5 mL (1 mg/mL) Single Dose Glass Fliptop Vial Novaplus (NDC 0409-2305-50)Available Hospira, Inc., a Pfizer Company In shortage Oct 29, 2026 None Midazolam Hydrochloride, Injection, 10 mg/10 mL (1 mg/mL) (NDC 0409-2587-05)Unavailable Hospira, Inc., a Pfizer Company In shortage Oct 29, 2026 Next Delivery: January 2027; Estimated Recovery: March 2027 Midazolam Hydrochloride Preservative Free, Injection, 5 mg/5 mL (1 mg/mL) (NDC 0409-2305-05)Limited Availability Hospira, Inc., a Pfizer Company In shortage Oct 29, 2026 Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: March 2027 Midazolam Hydrochloride Preservative Free, Injection, 5 mg/mL (5 mg/mL) (NDC 0409-2308-01)Unavailable Hospira, Inc., a Pfizer Company In shortage Oct 29, 2026 Next Delivery: November 2026; Estimated Recovery: December 2026 Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-661-10)Unavailable Gland Pharma Limited In shortage Oct 21, 2026 Estimated recovery: TBD; Distributed by Sagent Pharmaceuticals Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 25021-655-02)Unavailable Gland Pharma Limited In shortage Oct 21, 2026 Estimated recovery: TBD; Distributed by Sagent Pharmaceuticals Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6056-10)Available Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Additional lots are scheduled to be manufactured. Product will be made available as it is released. Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 0641-6060-10)Available Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Additional lots are scheduled to be manufactured. Product will be made available as it is released. Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 0641-6061-25)Available Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Additional lots are scheduled to be manufactured. Product will be made available as it is released. Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6057-25)Available Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Additional lots are scheduled to be manufactured. Product will be made available as it is released. Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6059-01)Available Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Additional lots are scheduled to be manufactured. Product will be made available as it is released. Morphine Sulfate Injection
In shortageInjection · 5 companies
Reasons: Demand increase for the drug; Discontinuation of the manufacture of the drug; Other
Updated Nov 9, 2026
24 presentationsHide detailsPresentation Company Status Updated FDA note Morphine Sulfate, Injection, 4 mg/1 mL Syringes (NDC 0409-1891-01)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Morphine Sulfate, Injection, 5 mg/10 mL (0.5 mg/mL) (NDC 0409-3814-12)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Morphine Sulfate, Injection, 10 mg/1 mL Syringes (NDC 0409-1893-01)Unavailable Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 Discontinuation of the manufacture of the drug Morphine Sulfate, Injection, 2 mg/1 mL Syringes (NDC 0409-1890-01)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Morphine Sulfate, Injection, 1 mg/1 mL (NDC 76329-1912-1)Available Amphastar Pharmaceuticals, Inc. In shortage Nov 6, 2026 None Morphine Sulfate, Injection, 4 mg/1 mL (NDC 63323-454-01)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Morphine Sulfate, Injection, 10 mg/1 mL (NDC 63323-451-01)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Morphine Sulfate, Injection, 2 mg/1 mL (NDC 76045-004-11)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Morphine Sulfate, Injection, 2 mg/1 mL (NDC 63323-452-01)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Next release December 2026. Check wholesalers for inventory. Morphine Sulfate, Injection, 5 mg/1 mL (NDC 63323-455-01)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Estimated recovery: TBD Morphine Sulfate, Injection, 4 mg/1 mL (NDC 76045-005-11)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Morphine Sulfate, Injection, 10 mg/10 mL (1 mg/mL) (NDC 0409-3815-12)Limited Availability Hospira, Inc., a Pfizer Company In shortage Oct 21, 2026 Limited Supply Available. Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay Morphine Sulfate, Injection, 2 mg/1 mL (NDC 0409-1890-23)Limited Availability Hospira, Inc., a Pfizer Company In shortage Oct 21, 2026 Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay Morphine Sulfate, Injection, 50 mg/1 mL (NDC 0409-2022-01)Unavailable Hospira, Inc., a Pfizer Company In shortage Oct 21, 2026 Next Delivery: February 2027; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay Morphine Sulfate, Injection, 50 mg/1 mL (NDC 0409-1896-20)Unavailable Hospira, Inc., a Pfizer Company In shortage Oct 21, 2026 Next Delivery: February 2027; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay Infumorph 500 (Preservative-Free Morphine Sulfate Sterile Solution), Injection, 25 mg/1 mL (NDC 0641-6040-01)Available Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Additional lots are scheduled to be manufactured. Product will be made available as it is released. Morphine Sulfate, Injection, 10 mg/1 mL (NDC 0641-6127-25)Available Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Additional lots are scheduled to be manufactured. Product will be made available as it is released. Duramorph, Injection, .5 mg/1 mL (NDC 0641-6020-10)Available Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Additional lots are scheduled to be manufactured. Product will be made available as it is released. Infumorph 200 (Preservative-Free Morphine Sulfate Sterile Solution), Injection, 10 mg/1 mL (NDC 0641-6039-01)Unavailable Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Additional lots will be available in the November 2026 timeframe. Product will be made available as it is released. Morphine Sulfate, Injection, 4 mg/1 mL (NDC 0641-6125-25)Available Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Additional lots are scheduled to be manufactured. Product will be made available as it is released. Duramorph, Injection, 1 mg/1 mL (NDC 0641-6019-10)Available Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Additional lots are scheduled to be manufactured. Product will be made available as it is released. Morphine Sulfate, Injection, 8 mg/1 mL (NDC 0641-6126-25)Available Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Additional lots are scheduled to be manufactured. Product will be made available as it is released. Mitigo, Injection, 200 mg/20 mL (NDC 66794-160-02)Available Piramal Critical Care Inc. In shortage Sep 15, 2026 None Mitigo, Injection, 500 mg/20 mL (NDC 66794-162-02)Available Piramal Critical Care Inc. In shortage Sep 15, 2026 None Promethazine Hydrochloride Injection
In shortageInjection · 2 companies
Reasons: Demand increase for the drug; Other
Updated Oct 14, 2026
10 presentationsHide detailsPresentation Company Status Updated FDA note Phenergan, Injection, 25 mg/1 mL (NDC 0641-6082-25)Available Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Additional lots are scheduled to be manufactured. Product will be made available as it is released. Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-1496-35)Available Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Additional lots are scheduled to be manufactured. Product will be made available as it is released. Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-0928-25)Available Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Additional lots are scheduled to be manufactured. Product will be made available as it is released. Phenergan, Injection, 25 mg/1 mL (NDC 0641-6084-25)Unavailable Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Estimated recovery: TBD Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-0929-25)Unavailable Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Estimated recovery: TBD Phenergan, Injection, 50 mg/1 mL (NDC 0641-6083-25)Available Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Additional lots are scheduled to be manufactured. Product will be made available as it is released. Phenergan, Injection, 50 mg/1 mL (NDC 0641-6085-25)Unavailable Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Estimated recovery: TBD Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-1495-35)Unavailable Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Additional lots will be available in the November 2026 timeframe. Product will be made available as it is released. Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 39822-5525-3)Available XGen Pharmaceuticals DJB, Inc. In shortage Sep 22, 2026 None Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 39822-5550-6)Unvailable XGen Pharmaceuticals DJB, Inc. In shortage Sep 22, 2026 Estimated recovery: TBD Remifentanil Hydrochloride Injection
In shortageInjection · 3 companies
Reasons: Delay in shipping of the drug; Demand increase for the drug
Updated Nov 3, 2026
9 presentationsHide detailsPresentation Company Status Updated FDA note Ultiva, Injection, 1 mg/1 mL (NDC 72078-034-01)Available Mylan Institutional, a Viatris Company In shortage Nov 3, 2026 None Ultiva, Injection, 5 mg (NDC 72078-036-05)Available Mylan Institutional, a Viatris Company In shortage Nov 3, 2026 None Ultiva, Injection, 2 mg (NDC 72078-035-02)Available Mylan Institutional, a Viatris Company In shortage Nov 3, 2026 None Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-724-05)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-725-10)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-723-03)Unavailable Fresenius Kabi USA, LLC In shortage Oct 15, 2026 Next release November 2026. Check wholesalers for inventory. Remifentanil Hydrochloride, Injection, 5 mg per vial (NDC 0143-9393-10)Unavailable Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Estimated recovery: TBD Remifentanil Hydrochloride, Injection, 1 mg per vial (NDC 0143-9391-10)Unavailable Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Estimated recovery: TBD Remifentanil Hydrochloride, Injection, 2 mg per vial (NDC 0143-9392-10)Unavailable Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Estimated recovery: TBD Rocuronium Bromide Injection
In shortageInjection · 11 companies
Reasons: Delay in shipping of the drug; Demand increase for the drug
Updated Nov 9, 2026
26 presentationsHide detailsPresentation Company Status Updated FDA note Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-95)Available Sandoz Inc. In shortage Nov 9, 2026 None Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-1403-10)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-5160-10)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-3189-10)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-7037-10)Available Hospira, Inc., a Pfizer Company In shortage Nov 9, 2026 None Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-92)Available Sandoz Inc. In shortage Nov 9, 2026 None Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 25021-687-05)Available Sagent Pharmaceuticals In shortage Nov 6, 2026 None Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-442-05)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-10)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-05)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Next release December 2026. Check wholesalers for inventory. Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-10)Available Mylan Institutional, a Viatris Company In shortage Nov 3, 2026 None Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-444-10)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-05)Available Mylan Institutional, a Viatris Company In shortage Nov 3, 2026 None Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 43066-007-10)Available Baxter Healthcare In shortage Nov 3, 2026 None Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-065-05)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Estimated recovery: TBD Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 43066-013-10)Available Baxter Healthcare In shortage Nov 3, 2026 None Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 55150-225-05)Available Eugia US LLC In shortage Oct 19, 2026 Check wholesalers for inventory Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 55150-226-10)Available Eugia US LLC In shortage Oct 19, 2026 Check wholesalers for inventory Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9250-10)Available Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Additional lots will be available. Product will be made available as it is released. Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9251-10)Available Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Additional lots will be available. Product will be made available as it is released. Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 39822-4200-2)Available XGen Pharmaceuticals DJB, Inc. In shortage Sep 22, 2026 Tamarang is the application holder and X-Gen is the distributor/labeler Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 39822-4200-6)Available XGen Pharmaceuticals DJB, Inc. In shortage Sep 22, 2026 Tamarang is the application holder and X-Gen is the distributor/labeler Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 66794-229-41)Limited Availability Piramal Critical Care Inc. In shortage Sep 15, 2026 On allocation Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 66794-228-41)Available Piramal Critical Care Inc. In shortage Sep 15, 2026 None Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-700-06)Available Meitheal Pharmaceuticals, Inc. In shortage Aug 27, 2026 None Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-718-11)Available Meitheal Pharmaceuticals, Inc. In shortage Aug 27, 2026 None Ropivacaine Hydrochloride Injection
In shortageInjection · 5 companies
Reasons: Delay in shipping of the drug; Demand increase for the drug; Other
Updated Nov 3, 2026
49 presentationsHide detailsPresentation Company Status Updated FDA note Naropin, Injection, 10 mg/1 mL (NDC 63323-288-10)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Estimated recovery: TBD Naropin, Injection, 7.5 mg/1 mL (NDC 63323-287-20)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Estimated recovery: TBD Naropin, Injection, 2 mg/1 mL (NDC 63323-285-61)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Estimated recovery: TBD Naropin, Injection, 2 mg/1 mL (NDC 63323-285-65)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Naropin, Injection, 2 mg/1 mL (NDC 63323-285-20)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Estimated recovery: TBD Naropin, Injection, 2 mg/1 mL (NDC 63323-285-13)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Next release not available at this time. Check wholesalers for inventory. Naropin, Injection, 5 mg/1 mL (NDC 63323-286-23)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 None Naropin, Injection, 2 mg/1 mL (NDC 65219-632-10)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 None Naropin, Injection, 5 mg/1 mL (NDC 63323-286-00)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 None Naropin, Injection, 2 mg/1 mL (NDC 63323-285-63)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Estimated recovery: TBD Naropin, Injection, 2 mg/1 mL (NDC 63323-285-10)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Estimated recovery: TBD Naropin, Injection, 5 mg/1 mL (NDC 63323-286-63)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 None Naropin, Injection, 5 mg/1 mL (NDC 63323-286-20)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Estimated recovery: TBD Naropin, Injection, 7.5 mg/1 mL (NDC 63323-287-21)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Naropin, Injection, 10 mg/1 mL (NDC 63323-288-11)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 None Naropin, Injection, 2 mg/1 mL (NDC 63323-285-23)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Naropin, Injection, 10 mg/1 mL (NDC 63323-288-21)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 None Naropin, Injection, 5 mg/1 mL (NDC 63323-286-31)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Estimated recovery: TBD Naropin, Injection, 5 mg/1 mL (NDC 63323-286-35)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Check wholesalers for inventory Naropin, Injection, 10 mg/1 mL (NDC 63323-288-20)Unavailable Fresenius Kabi USA, LLC In shortage Nov 3, 2026 Estimated recovery: TBD Naropin, Injection, 2 mg/1 mL (NDC 63323-285-64)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 None Naropin, Injection, 2 mg/1 mL (NDC 65219-632-20)Available Fresenius Kabi USA, LLC In shortage Nov 3, 2026 None Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-87)Available InfoRLife SA In shortage Nov 2, 2026 Marketed by Sagent Pharmaceuticals Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-82)Available InfoRLife SA In shortage Nov 2, 2026 Marketed by Sagent Pharmaceuticals Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-66)Limited Availability InfoRLife SA In shortage Nov 2, 2026 Estimated recovery: TBD; Marketed by Sagent Pharmaceuticals Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-87)Available InfoRLife SA In shortage Nov 2, 2026 Marketed by Sagent Pharmaceuticals Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-82)Available InfoRLife SA In shortage Nov 2, 2026 Marketed by Sagent Pharmaceuticals Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-67)Unavailable InfoRLife SA In shortage Nov 2, 2026 Estimated recovery: TBD; Marketed by Sagent Pharmaceuticals Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-01)Available Somerset Therapeutics, LLC In shortage Oct 27, 2026 None Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-062-25)Available Somerset Therapeutics, LLC In shortage Oct 27, 2026 None Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-062-10)Available Somerset Therapeutics, LLC In shortage Oct 27, 2026 None Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-063-25)Available Somerset Therapeutics, LLC In shortage Oct 27, 2026 None Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-10)Available Somerset Therapeutics, LLC In shortage Oct 27, 2026 None Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 70069-067-25)Available Somerset Therapeutics, LLC In shortage Oct 27, 2026 None Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-061-25)Available Somerset Therapeutics, LLC In shortage Oct 27, 2026 None Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 70069-067-10)Available Somerset Therapeutics, LLC In shortage Oct 27, 2026 None Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-25)Available Somerset Therapeutics, LLC In shortage Oct 27, 2026 None Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-061-10)Available Somerset Therapeutics, LLC In shortage Oct 27, 2026 None Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 55150-196-99)Available Eugia US LLC In shortage Oct 19, 2026 Check wholesalers for inventory Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-197-20)Available Eugia US LLC In shortage Oct 19, 2026 Check wholesalers for inventory Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-200-10)Available Eugia US LLC In shortage Oct 19, 2026 Check wholesalers for inventory Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-201-20)Available Eugia US LLC In shortage Oct 19, 2026 Check wholesalers for inventory Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-198-30)Available Eugia US LLC In shortage Oct 19, 2026 Check wholesalers for inventory Ropivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 55150-199-20)Unavailable Eugia US LLC In shortage Oct 19, 2026 On backorder. Recovery: TBD. Check wholesalers for inventory Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 55150-195-20)Unavailable Eugia US LLC In shortage Oct 19, 2026 On backorder. Recovery: TBD. Check wholesalers for inventory Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 43066-023-10)Limited Availability Caplin Steriles, Ltd. In shortage Jun 10, 2026 Limited supply; Check wholesalers for inventory; Marketed by Baxter Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 43066-019-10)Available Caplin Steriles, Ltd. In shortage Jun 10, 2026 Check wholesalers for inventory; Marketed by Baxter Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 43066-015-10)Limited Availability Caplin Steriles, Ltd. In shortage Jun 10, 2026 Check wholesalers for inventory; Marketed by Baxter Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 43066-027-10)Available Caplin Steriles, Ltd. In shortage Jun 10, 2026 Check wholesalers for inventory; Marketed by Baxter Sufentanil Citrate Injection
In shortageInjection · 2 companies
Reason: Other
Updated Oct 21, 2026
4 presentationsHide detailsPresentation Company Status Updated FDA note Sufentanil Citrate, Injection, 50 ug/1 mL (NDC 0409-3382-21)Limited Availability Hospira, Inc., a Pfizer Company In shortage Oct 21, 2026 Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-02)Unavailable Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Not currently manufactured Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-05)Unavailable Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Not currently manufactured Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-01)Unavailable Hikma Pharmaceuticals USA, Inc. In shortage Oct 14, 2026 Not currently manufactured Aspirin Suppository
To be discontinuedSuppository · 1 company
Updated Jul 23, 2026
1 presentationHide detailsPresentation Company Status Updated FDA note Aspirin, Suppository, 300 mg (NDC 0574-7034-12) Padagis US LLC To be discontinued Jul 23, 2026 Discontinuation of the manufacture of the drug Belladonna and Opium Suppository
To be discontinuedSuppository · 1 company
Updated Jul 23, 2026
4 presentationsHide detailsPresentation Company Status Updated FDA note Belladonna and Opium, Suppository, 16.2 mg; 60 mg (NDC 0574-7040-04) Padagis US LLC To be discontinued Jul 23, 2026 Discontinuation of the manufacture of the drug Belladonna and Opium, Suppository, 16.2 mg; 30 mg (NDC 0574-7045-12) Padagis US LLC To be discontinued Jul 23, 2026 Discontinuation of the manufacture of the drug Belladonna and Opium, Suppository, 16.2 mg; 60 mg (NDC 0574-7040-12) Padagis US LLC To be discontinued Jul 23, 2026 Discontinuation of the manufacture of the drug Belladonna and Opium, Suppository, 16.2 mg; 30 mg (NDC 0574-7045-04) Padagis US LLC To be discontinued Jul 23, 2026 Discontinuation of the manufacture of the drug Cisatracurium Besylate Injection
To be discontinuedInjection · 1 company
Updated Sep 11, 2026
3 presentationsHide detailsPresentation Company Status Updated FDA note Cisatracurium Besylate, Injection, 10 mg/5ml (2 mg/mL) Single Dose Vial (NDC 0409-1098-02) Hospira, Inc., a Pfizer Company To be discontinued Sep 11, 2026 Supply expected to exhaust November 2026; Discontinuation of the manufacture of the drug Cisatracurium Besylate, Injection, 20 mg/10 mL (2 mg/mL) Multidose Vial (NDC 0409-1208-01) Hospira, Inc., a Pfizer Company To be discontinued May 6, 2026 Supply expected to exhaust late June 2026; Discontinuation of the manufacture of the drug Cisatracurium Besylate, Injection, 200 mg/20ml (10 mg/mL) Single Dose Vial (NDC 0409-1103-01) Hospira, Inc., a Pfizer Company To be discontinued May 6, 2026 Supply expected to exhaust late June 2026; Discontinuation of the manufacture of the drug Desflurane Liquid for Inhalation
To be discontinued1 company
Updated Jul 2, 2026
1 presentationHide detailsPresentation Company Status Updated FDA note Desflurane, Liquid for Inhalation, 240 mL/240 mL (NDC 0781-6172-86) Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) To be discontinued Jul 2, 2026 Discontinuation of the manufacture of the drug; Distributed by Sandoz, Inc. Glycopyrrolate Injection
To be discontinuedInjection · 1 company
Updated Jul 30, 2026
4 presentationsHide detailsPresentation Company Status Updated FDA note Glycopyrrolate, Injection, 0.4 mg per 2 mL (NDC 63323-578-02) Fresenius Kabi USA, LLC To be discontinued Jul 30, 2026 Discontinuation of the manufacture of the drug Glycopyrrolate, Injection, .2 mg/1 mL (NDC 63323-578-01) Fresenius Kabi USA, LLC To be discontinued Jul 30, 2026 Discontinuation of the manufacture of the drug Glycopyrrolate, Injection, 0.2 mg per 1 mL (NDC 65219-801-01) Fresenius Kabi USA, LLC To be discontinued Jul 30, 2026 Discontinuation of the manufacture of the drug Glycopyrrolate, Injection, 1 mg per 5 mL (NDC 63323-578-05) Fresenius Kabi USA, LLC To be discontinued Jul 30, 2026 Discontinuation of the manufacture of the drug Hydrocortisone Acetate Suppository
To be discontinuedSuppository · 1 company
Updated Jul 23, 2026
2 presentationsHide detailsPresentation Company Status Updated FDA note Hydrocortisone Acetate, Suppository, 30 mg (NDC 0574-7093-12) Padagis US LLC To be discontinued Jul 23, 2026 Discontinuation of the manufacture of the drug Hydrocortisone Acetate, Suppository, 25 mg (NDC 0574-7090-12) Padagis US LLC To be discontinued Jul 23, 2026 Discontinuation of the manufacture of the drug Hydromorphone Hydrochloride Suppository
To be discontinuedSuppository · 1 company
Updated Jul 23, 2026
1 presentationHide detailsPresentation Company Status Updated FDA note Hydromorphone Hydrochloride, Suppository, 3 mg (NDC 0574-7224-06) Padagis US LLC To be discontinued Jul 23, 2026 Discontinuation of the manufacture of the drug Ketorolac Tromethamine Tablet
To be discontinuedTablet · 1 company
Updated Apr 20, 2026
1 presentationHide detailsPresentation Company Status Updated FDA note Ketorolac Tromethamine, Tablet, 10 mg (NDC 0378-1134-01) Mylan Pharmaceuticals Inc., a Viatris Company To be discontinued Apr 20, 2026 Discontinuation of the manufacture of the drug Morphine Sulfate Suppository
To be discontinuedSuppository · 1 company
Updated Jul 23, 2026
4 presentationsHide detailsPresentation Company Status Updated FDA note Morphine Sulfate, Suppository, 5 mg (NDC 0574-7110-12) Padagis US LLC To be discontinued Jul 23, 2026 Discontinuation of the manufacture of the drug Morphine Sulfate, Suppository, 30 mg (NDC 0574-7116-12) Padagis US LLC To be discontinued Jul 23, 2026 Discontinuation of the manufacture of the drug Morphine Sulfate, Suppository, 20 mg (NDC 0574-7114-12) Padagis US LLC To be discontinued Jul 23, 2026 Discontinuation of the manufacture of the drug Morphine Sulfate, Suppository, 10 mg (NDC 0574-7112-12) Padagis US LLC To be discontinued Jul 23, 2026 Discontinuation of the manufacture of the drug Morphine Sulfate Tablet
To be discontinuedTablet · 1 company
Updated Dec 22, 2025
2 presentationsHide detailsPresentation Company Status Updated FDA note Morphine Sulfate, Tablet, 30 mg (NDC 0832-0274-11) Upsher-Smith Laboratories, LLC To be discontinued Dec 22, 2025 Discontinuation of the manufacture of the drug Morphine Sulfate, Tablet, 15 mg (NDC 0832-0273-11) Upsher-Smith Laboratories, LLC To be discontinued Dec 22, 2025 Discontinuation of the manufacture of the drug Neostigmine Methylsulfate Injection
To be discontinuedInjection · 1 company
Updated Jan 12, 2026
1 presentationHide detailsPresentation Company Status Updated FDA note Neostigmine Methylsulfate, Injection, .5 mg/1 mL (NDC 63323-413-10) Fresenius Kabi USA, LLC To be discontinued Jan 12, 2026 Discontinuation of the manufacture of the drug Nitroglycerin Ointment
To be discontinuedOintment · 1 company
Updated Apr 14, 2026
1 presentationHide detailsPresentation Company Status Updated FDA note Rectiv, Ointment, 0.4% (NDC 58914-301-80) AbbVie Inc. To be discontinued Apr 14, 2026 Discontinuation of the manufacture of the drug Succinylcholine Chloride Injection
To be discontinuedInjection · 1 company
Updated Jul 23, 2026
1 presentationHide detailsPresentation Company Status Updated FDA note Succinylcholine Chloride, Injection, 20 mg/1 mL (NDC 63323-943-10) Fresenius Kabi USA, LLC To be discontinued Jul 23, 2026 Discontinuation of the manufacture of the drug
This list is drawn from the U.S. Food and Drug Administration’s public Drug Shortages database through the openFDA API, curated to the drugs used in anesthesia and perioperative care. It is national data gathered for South Carolina physician anesthesiologists, not a South-Carolina-specific supply report. The tracker was last refreshed on November 10, 2026.
The data may lag the FDA’s own site, and it is provided for awareness only. It is not a basis for medical care decisions, and you should not rely on it to make decisions about patient care. Confirm current status with the FDA Drug Shortages database and your own pharmacy. Data via openFDA.
The American Society of Health-System Pharmacists (ASHP) maintains the drug shortage list that most hospitals and pharmacies treat as the practitioner source of record. ASHP collects reports from manufacturers and practitioners directly, so its entries often appear sooner and carry management advice. Check the ASHP current shortages list alongside this tracker.